Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
An update from Faron Pharmaceuticals Oy ( (GB:FARN) ) is now available.
Faron Pharmaceuticals is conducting a private placement aiming to raise approximately EUR 10 million through an accelerated book-building process, involving institutional investors. These funds will bolster the company’s financial position, supporting the continuation of its BEXMAB Phase II trial and enhancing its negotiation leverage for future business transactions, all while ensuring compliance with financial covenants.
More about Faron Pharmaceuticals Oy
Faron Pharmaceuticals Oy is a clinical-stage biopharmaceutical company based in Turku, Finland, specializing in developing novel immunotherapies for cancer treatment. The company is focused on advancing its pipeline, particularly the development of bexmarilimab, a potential cancer treatment.
YTD Price Performance: -23.17%
Average Trading Volume: 16,588
Technical Sentiment Consensus Rating: Buy
Current Market Cap: £167.1M
For a thorough assessment of FARN stock, go to TipRanks’ Stock Analysis page.
